Company | Name | Exchange | Sector | Industry | Piotroski Score | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upgrade to Pro+ | London | Basic Materials | Metals & Mining | Upgrade to Pro+ | £14.58Cr | 3.6x | 0.11 | GBX 21.50 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.2% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | London | Financial | Investment Banking & Investment Services | Upgrade to Pro+ | £23.88Cr | 4.5x | 0.04 | GBX 642.50 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.9% Downside | Upgrade to Pro+ | |
Upgrade to Pro+ | London | Energy | Oil & Gas Related Equipment and Services | Upgrade to Pro+ | £156.76Cr | 3.6x | 0.24 | GBX 1,033.62 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | London | Healthcare | Pharmaceuticals | Upgrade to Pro+ | £91.37Cr | 15.7x | 0.03 | GBX 5,693.30 | 17.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | London | Healthcare | Pharmaceuticals | Upgrade to Pro+ | £18.73Cr | 2.9x | 0.02 | GBX 1,499.83 | 73.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | London | Technology | Software & IT Services | Upgrade to Pro+ | £12.23KCr | 10.2x | 0.08 | GBX 10,692.53 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |